Viatris Pharma GmbH - Olmesartan HCT Viatris 20/12.5 mg, Fimtabletten | | 66803 | | 01 | | Olmesartan HCT Viatris 20/12.5 mg | | Fimtabletten | | C09DA08 | | Olmesartan medoxomil and diuretics | | 19.07.2018 | | |
| Composition | olmesartanum medoxomilum 20 mg, hydrochlorothiazidum 12.5 mg, carmellosum natricum conexum, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 6000, talcum, E 171, pro compresso obducto, natrium 1.4837 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Olmesartanum Medoxomilum | 20 mg |
| BAG: Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Olmesartan Medoxomil | 20 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | Hydroxypropylcellulosum Substitutum Humile | | | Hypromellosum | | Überzug | Macrogol | 6000 | | Magnesii Stearas | | | Mannitol | | | Natrii Laurilsulfas | | | Sodium | 1.4837 mg | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
009 | 28 | 13.44 | 27.75 | B | LS | Non | 010 | 98 | 40.04 | 62.45 | B | LS | Non |
|
|